Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01920828 · ClinicalTrials.gov registry record
Gait Analysis in MPS IVA
A clinical trial of MPS IVA and Morquio Syndrome, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT01920828 is a study of MPS IVA and Morquio Syndrome that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants, below the 67-participant average among 5 other MPS IVA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01920828, a study of MPS IVA and Morquio Syndrome, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and possible changes in gait with enzyme replacement therapy.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01920828
The ClinicalTrials.gov registry entry for NCT01920828 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 5 other MPS IVA trials with a reported enrollment target (85% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with MPS IVA appearing as the primary indexed condition, and to 0 interventions.
NCT01920828 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01920828 about?
NCT01920828 is a clinical study titled "Gait Analysis in MPS IVA". The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and possible changes in gait with enzyme replacement therapy.
What is the current status of trial NCT01920828?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2017-06.
What conditions does trial NCT01920828 study?
This clinical trial studies the following conditions: MPS IVA, Morquio Syndrome.
Who is sponsoring clinical trial NCT01920828?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01920828 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MPS IVA
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Functional Assessment and Pathogenesis of Morquio A
RECRUITING
-
Cardiac Structure and Function in MPS
RECRUITING
-
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
RECRUITING · Phase 1
-
Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI
ACTIVE NOT RECRUITING · Phase 1
-
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.